New Therapeutic Targets in Alzheimer's Disease
Sign Up to like & getrecommendations! Published in 2017 at "International Journal of Gerontology"
DOI: 10.1016/j.ijge.2016.07.003
Abstract: Summary Up to the present, the identification of neurochemical alterations underlying Alzheimer's disease allowed for the development of the first generation of therapies that are somewhat specific for this disorder. Although both cholinesterase inhibitors and… read more here.
Keywords: alzheimer disease; therapeutic targets; targets alzheimer; new therapeutic ... See more keywords
Multiomics Identification of Potential Targets for Alzheimer Disease and Antrocin as a Therapeutic Candidate
Sign Up to like & getrecommendations! Published in 2021 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics13101555
Abstract: Alzheimer’s disease (AD) is the most frequent cause of neurodegenerative dementia and affects nearly 50 million people worldwide. Early stage diagnosis of AD is challenging, and there is presently no effective treatment for AD. The… read more here.
Keywords: alzheimer disease; multiomics identification; disease; potential targets ... See more keywords
CD34+ progenitor cells as diagnostic and therapeutic targets in Alzheimer’s disease
Sign Up to like & getrecommendations! Published in 2022 at "Neural Regeneration Research"
DOI: 10.4103/1673-5374.346485
Abstract: COMMENTS TO AUTHORS In this manuscript entitled "Hematopoietic progenitor cells as diagnostic and therapeutic targets in Alzheimer's disease", the authors reviewed the recent work and ongoing clinical trials testing the feasibility of Hematopoietic progenitor cells… read more here.
Keywords: progenitor; targets alzheimer; diagnostic therapeutic; cells diagnostic ... See more keywords